Site Members can sign up for company wide alerts
Investigation Overview
October 25, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Repros Therapeutics Inc (NASDAQ:RPRX) shares over potential securities laws violations by Repros Therapeutics Inc and certain of its directors and officers in connection certain statements over its Androxal was announced. The investigation by a law firm focuses on possible claims on behalf of purc...
You must register (for free) or login to view the entire investigation.